Pharma Journalist - Page 822 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Pfizer announces FDA approval of XELJANZ (tofacitinib) and XELJANZ XR

FDA Grants Orphan Drug Designation to Zytoprotec’s Novel Dialysis Fluid

PAREXEL Launches Perceptive Cloud for the Life Sciences Industry

STORM Therapeutics Joins SMi’s 9th Annual RNA Therapeutics

SGS Launches New Large Molecule Bioanalytical Services

Abzena secures ADC manufacturing services contract

MeiraGTx receives rare pediatric disease designation for gene therapy A001

Carmot enters a Multi-Year Drug Discovery Collaboration with Amgen

Aerogen & Lyomark Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial

Gilead Sciences and Kite to acquire Cell Design Labs